ONS and other groups ask nurses to lead by example to promote advance care planning

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Advance care planning is a process for patients and their families to discuss their wishes and goals of care for treatment and end-of-life care, clarify related values and goals, and state preferences through written documents and medical orders.

In situations where a patient’s decision-making capacity is limited, healthcare providers turn to family members to make decisions.

The Oncology Nursing Society has joined with nursing specialty organizations representing more than 700,000 nurses and other healthcare professionals to promote those ACP conversations among patients and families. The initiative encourages all nurses to lead by example by establishing their own ACP.

The initiative, tagged “#ISaidWhatIWant,” was developed in response to the work done at the 2017 Palliative Nursing Summit hosted by the Hospice and Palliative Care Nursing Association, in which ONS participated.

The summit brought nurses together from various specialties to develop a collaborative nursing agenda regarding ACP, pain and symptom management, and transitions/coordination of care.

Following the summit, participating organizations formed work teams to develop specific programs to influence public health by engaging nurses in targeted initiatives to enhance the care and outcomes for patients and their families.

Table of Contents

YOU MAY BE INTERESTED IN

Physician-scientists by day, a funk-loving musical troupe by night. You may have seen The CheckPoints—a 13 member cover band with a three-piece brass section and Jim Allison on harmonica—movin’, groovin’, and gettin’ down as a mainstay closing act at ASCO, AACR, or the Society for Immunotherapy of Cancer annual meetings.
At the 2026 Annual Meeting of the American Society of Clinical Oncology in Chicago, results from the phase III HARMONi-6 trial were presented at the plenary session and published simultaneously in The Lancet. The HARMONi-6 trial tested a novel bispecific antibody that engages PD-1 and VEGF (ivonescimab), given with platinum-doublet chemotherapy to patients with previously untreated advanced squamous non-small cell lung cancer. 
In 2026, more than 900 million people are estimated to be regularly using generative artificial intelligence—computer systems capable of creating human-like text, images, audio, video, and other original content. AI is becoming integrated into nearly every aspect of daily life. Health care is no exception. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login